Literature DB >> 6608695

Anti-idiotypic cytotoxic T cells in rats with graft-versus-host disease.

H Kimura, D B Wilson.   

Abstract

Transfer of parental strain T lymphocytes into F1 hybrid rats differing with respect to gene products of the major histocompatibility complex (MHC) causes a graft-versus-host (GvH) reaction. This reaction results from recognition of host allogeneic MHC gene products by specific clones of donor T cells. When given systemically in sufficient numbers, these donor T cells cause a progressive, generally fatal wasting syndrome, an early feature of which includes extensive splenomegaly. A more local, non-fatal GvH reaction, marked by extensive enlargement of the draining lymph nodes, ensues when donor T cells are administered via the footpad. Here, we demonstrate that cells derived from the enlarged draining lymph nodes of A/B F1 animals undergoing local GvH disease caused by donor A T cells contain a subpopulation of host-derived killer T-cell precursors which can be activated to lyse specific blast cells, derived from mixed lymphocyte culture (MLC), reactive to host MHCb alloantigens. These 'anti-idiotypic' cytolytic T cells lyse A anti-MHCb MLC blasts, and also, they lyse anti-MHCb MLC blasts from MHC different, third party rat strains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608695     DOI: 10.1038/308463a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  13 in total

Review 1.  Homeostatic control of immunity by TCR peptide-specific Tregs.

Authors:  Vipin Kumar
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  Staphylococcal enterotoxin B-induced T-cell anergy is mediated by regulatory T cells.

Authors:  Z Q Wang; T Orlikowsky; A Dudhane; V Trejo; G E Dannecker; B Pernis; M K Hoffmann
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

3.  Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system.

Authors:  W F Hickey; H Kimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Experimental studies of immunologically mediated enteropathy. III. Severe and progressive enteropathy during a graft-versus-host reaction in athymic mice.

Authors:  A M Mowat; M V Felstein; M E Baca
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

5.  Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones.

Authors:  P V Lehmann; K Drexler; M Tary-Lehmann; F Falcioni; U Hurtenbach; Z A Nagy
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

6.  In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors.

Authors:  D R Martin; R G Miller
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

7.  Immunogenicity and crossreactivity of specificity-associated markers on alloreactive T cells. Confirmation based on the model of tolerance abolition by adoptive transfer.

Authors:  H Kimura; W K Silvers; D B Wilson
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

8.  Generation of T cells with lytic specificity for atypical antigens. III. Priming F1 animals with antigen-bearing cells also having reactivity for host alloantigens allows for potent lytic T cell responses.

Authors:  J D Davies; D H Wilson; D B Wilson
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

9.  Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein.

Authors:  M Owhashi; E Heber-Katz
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.

Authors:  R Sorokin; H Kimura; K Schroder; D H Wilson; D B Wilson
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.